Alterations in superoxide dismutase activities, lipid peroxidation and glutathione levels in thinner inhaled rat lungs: Relationship between histopathological properties

Pharmacological Research

Volumn 38, Issue 3, 1998, Pages 209-214

  Ulakoǧlu, Emel Zengin ^a   Saygi, Atilla ^b   Gümüştaş, Mustafa Koray ^a   Zor, Erkan ^b   Öztek, Ibrahim ^c   Kökoǧlu, Emine ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Heybeliada Chest Dis Thorac S   (Turkey)

^c GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Glutathione; Lipid peroxidation; Lung; Superoxide dismutase; Thinner

Indexed keywords

GLUTATHIONE; NARCOTIC AGENT; ORGANIC SOLVENT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THINNER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL PROLIFERATION; CONTROLLED STUDY; EMPHYSEMA; ENZYME ACTIVITY; EPITHELIUM CELL; EXTRAVASATION; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; LIPID PEROXIDATION; LUNG; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; LUNG PARENCHYMA; MALE; NONHUMAN; PAINT INDUSTRY; PNEUMONIA; PRIORITY JOURNAL; RAT;

EID: 0032167533     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0354     Document Type: Article

References (29)

1. 1. Nomiyama K, Nomiyama H. Three fatal cases of thinner-sniffing and experimental exposure to toluene in human and animals. Int Arch Occup Environ Health 1978; 41: 55-64.
2. 2. Chalmers EM. Volatile substance abuse. Med J Aust 1991; 154(4): 269-74.
3. 3. Flanagan RJ, Ruprah M, Meredith TJ, Ramsey JD. An introduction to the clinical toxicology of volatile substances. Drug Safe 1990; 5(5): 359-83.
4. 4. Sarvesvaran R, Hasnan J. Solvent abuse: a case report and a review. Malays J Pathol 1994; 16(2): 167-71.
5. 5. Meadows R, Verghese A. Medical complications of glue sniffing. South Med J 1996; 89(5): 455-62.
6. 6. Schikler KN, Lane EE, Seitz K, Collins WM. Solvent abuse associated pulmonary abnormalities. Am J Drug Alcohol Abuse 1981; 8: 75-81.
7. 7. Mattia CJ, LeBel CP, Bondy SC. Effects of toluene and its metabolites on cerebral reactive oxygen species generation. Biochem Pharmacol 1991; 42: 879-82.
8. 8. Mattia CJ, Adams JD, Bondy SC. Free radical induction in the brain and liver by products of toluene catabolism. Biochem Pharmacol 1993; 46: 103-10.
9. 9. Halliwel B, Gutteridge JMC. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 1986; 246: 501-14.
10. 10. Suleiman SA. Petroleum hydrocarbon toxicity in vitro. Effect of n-alkanes, benzene and toluene on pulmonary alveolar macrophages and lysosomal enzymes of the lung. Arch Toxicol 1987; 59: 402-7.
11. 11. Stickney JA, Roberts AE, Silverman DM, Schatz RA. The effect of m-xylene on rat lung benzo[a]pyrene metabolism and microsomal membrane lipids: comparison with p-xylene. Toxicology 1989; 58: 155-65.
12. 12. Angel MF, Ramasastry SS, Swartz WM, Narayanan K, Kuhns DB, Basford RE, Futrell JW. The critical relationship between free radicals and degrees of ischemia. Evidence for tissue intolerance of marginal perfusion. Plast Reconstr Surg 1988; 81: 233-9.
13. 13. Sun Y, Patternson TE, McCormick ML, Oberley LW, Osborne JW. Improved superoxide dismutase assay for clinical use. Clin Chem 1989; 35: 1265-6.
14. 14. Fairbanks VF, Klee GG. Biochemical aspects of hematology. In: Textbook of clinical chemistry. Tietz NW, ed. Philadelphia: Saunders Company, 1986: pp. 1508-10.
15. 15. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
16. 16. Rees DC, Wood RW, Laties VG. Evidence of tolerance following repeated exposure to toluene in the rat. Pharmacol Biochem Behav 1989; 32: 283-91.
17. 17. Wood RW, Colotla VA. Biphasic changes in mouse motor activity during exposure to toluene. Fundam Appl Toxicol 1990; 14: 6-14.
18. 18. Marjot R, McLeod AA. Chronic non-neurological toxicity from volatile substance abuse. Human Toxicol 1989; 8: 301-6.
19. 2+) ATPase and fluidity of synaptosomal membranes isolated from rat brain. Pharmacol Toxicol 1989; 65: 140-2.
20. 1 prevents and reverses toluene-induced increases in membrane fluidity and calcium levels in rat brain synaptosomes. Brain Res 1990; 508: 210-14.
21. 21. LeBel CP, Schatz RA. Effect of toluene on rat synaptosomal phospholipid methylation and membrane fluidity. Biochem Pharmacol 1989; 38: 4005-11.
22. 22. Mattia CJ, Ali SF, Bondy SC. Toluene-induced oxidative stress in several brain regions and other organs. Mol Chem Neuropathol 1993; 18: 313-28.
23. 450 by toluene. Int J Biochem 1994; 26(12): 1333-40.
24. 24. Dean RT, Hunt JV, Grant AJ, Yamamoto Y, Niki E. Free radical damage to proteins: the influence of the relative localization of radical generation, antioxidants and target proteins. Free Radic Biol Med 1991; 11: 161-8.
25. 25. Yu BP. Cellular defenses against damage from reactive oxygen species. Biol Rev 1994; 74: 139-62.
26. 26. Al-Alousi LM. Pathology of volatile substance abuse: a case report and a literature review. Med Sci Law 1989; 29(3): 189-208.
27. 27. Davies KJ. Protein modification by oxidants and the role of proteolytic enzymes. Biochem Soc Transact 1993; 21: 346-53.
28. 28. Cerutti PA, Trump BF. Inflammation and oxidative stress in carcinogenesis. Cancer Cells 1991; 3: 1-7.
29. 29. Barber DA, Harris SR. Oxygen free radicals and antioxidants: a review. Am Pharm 1994; NS 34(9): 26-35.